ELITE PHARMACEUTICALS INC News

Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate

NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced t

AccesswireMay 20 18:00

Elite Pharmaceuticals GAAP EPS of $0.00, Revenue of $15.54M

Seeking AlphaFeb 15 05:57

Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 Ended December 31, 2023 and Provides Conference Call Information

Conference Call Scheduled for Thursday, February 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty phar

AccesswireFeb 15 05:30

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024

Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024NORTHVALE, NJ / ACCESSWIRE / February 8, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "

AccesswireFeb 8 21:15

Elite Pharmaceuticals Files ANDA With US FDA to Market Central Nervous System Stimulant

Stockhouse Dec 26, 2023 20:00

Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC

NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announ

AccesswireDec 12, 2023 20:00

Elite Pharmaceuticals Reports Q3 Results

Seeking AlphaNov 15, 2023 06:38

Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 Ended September 30, 2023 and Provides Conference Call Information

Conference Call Scheduled for Wednesday, November 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / November 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty ph

AccesswireNov 15, 2023 06:35

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023

Financials for Second Quarter Fiscal Year 2024 Ended September 30, 2023 will be released on November 14, 2023NORTHVALE, NJ / ACCESSWIRE / November 10, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or th

AccesswireNov 11, 2023 00:30